Cookies en el sitio web de KCI
Utilizamos cookies para mejorar su experiencia de navegación en nuestro sitio web. Visite nuestra Privacy Policy para obtener más información acerca de las cookies y cómo las utilizamos. Recomendamos que acepte la utilización de cookies para una mejor navegación.
Accesibilidad | Sitemap | Contacto | Atención al cliente LLAMAR 900 100 835
España Change Country Acceda
Inicio  |  Indicaciones  |  Productos  |  Datos clínicos  |  Formación y educación  |  Para los pacientes  |  Atención al cliente
Usted está aquí Inicio > Noticias y prensa > Acelity Increases Focus on Growth, Expansion Opportunities

Acelity Increases Focus on Growth, Expansion Opportunities

Lanzamiento : 30 Noviembre 2015

 Appoints Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing

KCI, Leader in Advanced Wound Care Solutions

SAN ANTONIO, November 30, 2015 – Acelity L.P. Inc. announced today the appointment of Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing (SBD&L). Dennis joins Acelity as a member of the senior leadership team. 


In this position, Dennis will oversee strategic planning, portfolio management and business development including M&A, partnerships, alliances and other activities that support Acelity’s growth strategy. Dennis brings to Acelity more than 20 years of experience in guiding mergers and acquisitions, joint ventures and strategic affiliations in all regions of the world. His deep expertise in corporate transactions and demonstrated leadership abilities make him especially well-suited to working across countries and franchises to identify and aggressively pursue opportunities on behalf of Acelity.


“We have achieved significant results against our strategic imperative as we seek to establish Acelity as a global leader in medical technology,” said Joe Woody, President and CEO, Acelity. “As Acelity enters the next phase of its transformative journey, Dennis’ proven track record in leading business development and strategy make him a natural fit to drive and execute on our vision for growth in business segments and geographies around the world.”


Dennis joins Acelity from Medtronic and led previously the Covidien Global Business Development team prior to that merger, supporting business units and geographies while identifying new market opportunities. He is a graduate of Harvard College with a degree in Economics.


About Acelity

Acelity L.P. Inc. and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,700 people around the world.


For more information, contact:

Cheston Turbyfill
Corporate Communications
Phone: +1-210-515-7757
Caleb Moore
Investor Relations
Phone: +1-210-255-6433


  • Síganos en
  • Síganos en Twitter
  • Visite nuestra página en YouTube

Mensaje importante para los pacientes

Información legal | Política de privacidad | Contacto

La información de esta página está exclusivamente dirigida a los profesionales sanitarios.


© 1998 – 2013 KCI Licensing, Inc. Reservados todos los derechos.   DSL# 09-03-193.ES

La información incluida en este sitio web ha sido diseñada y elaborada para su consulta en España por los profesionales sanitarios exclusivamente. Si usted no es un profesional sanitario, no puede acceder a esta información. Este sitio web contiene información sobre productos que pueden no estar disponibles en todos los países y que, llegado el caso, pueden no haber sido aprobados ni autorizados para su comercialización por los organismos reguladores competentes por las diferentes indicaciones y restricciones de los distintos países.